KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Colgate Palmolive (CL) Dividends Paid - Common (2016 - 2025)

Colgate Palmolive (CL) has 17 years of Dividends Paid - Common data on record, last reported at $523.0 million in Q4 2025.

  • For Q4 2025, Dividends Paid - Common rose 1.75% year-over-year to $523.0 million; the TTM value through Dec 2025 reached $1.8 billion, up 1.9%, while the annual FY2025 figure was $1.8 billion, 1.9% up from the prior year.
  • Dividends Paid - Common reached $523.0 million in Q4 2025 per CL's latest filing, up from $420.0 million in the prior quarter.
  • Across five years, Dividends Paid - Common topped out at $523.0 million in Q4 2025 and bottomed at $376.0 million in Q1 2021.
  • Average Dividends Paid - Common over 5 years is $436.6 million, with a median of $420.0 million recorded in 2021.
  • Peak YoY movement for Dividends Paid - Common: surged 290.91% in 2021, then decreased 2.22% in 2022.
  • A 5-year view of Dividends Paid - Common shows it stood at $496.0 million in 2021, then fell by 2.22% to $485.0 million in 2022, then increased by 4.33% to $506.0 million in 2023, then rose by 1.58% to $514.0 million in 2024, then rose by 1.75% to $523.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Dividends Paid - Common were $523.0 million in Q4 2025, $420.0 million in Q3 2025, and $474.0 million in Q2 2025.